NCT04886388View on ClinicalTrials.gov

Pivotal Trial of a Digital Therapeutic for the Treatment of Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

668

Participants

Timeline

Start Date

April 22, 2021

Primary Completion Date

March 9, 2022

Study Completion Date

September 27, 2022

Conditions
Type 2 Diabetes
Interventions
DEVICE

BT-001

BT-001 is a software program intended to help patients with type 2 diabetes, under the guidance of their physician, improve glycemic control.

OTHER

Physician-guided Standard of Care for type 2 diabetes

Current ADA Standard of Care Guidelines for type 2 diabetes

Trial Locations (6)

10001

Study Site, New York

30301

Study Site, Atlanta

33101

Study Site, Miami

60007

Study Site, Chicago

77001

Study Site, Houston

94110

Study Site, San Francisco

Sponsors
All Listed Sponsors
lead

Better Therapeutics

INDUSTRY